Drug details
Kepivance (palifermin)
type of Adjunct Chemoprotective Agents, Keratinocyte Growth Factors
Kepivance (palifermin) for Injection is a human keratinocyte growth factor (KGF) produced by recombinant DNA technology used to reduce the chance of developing sores and ulcers in the mouth and to shorten the time with sores or ulcers in patients with blood cancers who receive high doses of chemotherapy and radiation therapy before bone marrow transplants.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- blurred vision,
- tunnel vision,
- eye pain, and
- seeing halos around lights